Are we heading into another “lost decade” for U.S. stocks?

Vanguard just released its latest 10-year market forecast — and the numbers are startling. With S&P 500 returns projected at only 2.8%–4.8% and large-cap growth even lower, long-term investors may face a dramatically different decade than the one we just lived through.

In this episode, Dr. Abhishek Gadre breaks down Vanguard’s Capital Markets Model (VCMM), explains why U.S. growth stocks look overvalued, and reveals the areas of the market that show real opportunity — including value stocks, small caps, international equities, and even bonds. You’ll hear why diversification matters more than ever—and the exact shifts he’s making in his own portfolio.

You Will Learn:
✅ Why Vanguard is projecting a weak decade for U.S. large-cap growth
✅ The mathematics behind “reversion to the mean” and valuation resets
✅ Why U.S. value and small caps are undervalued heading into 2026–2035
✅ Why international stocks may outperform U.S. equities for the first time in 15+ years
✅ Why bonds now offer higher expected returns with lower volatility
✅ How Morningstar and major banks compare to Vanguard’s outlook
✅ How to build a more resilient, globally diversified portfolio
✅ The portfolio changes Dr. Gadre personally made for the next decade

If the last decade rewarded concentrated bets, the next decade may reward disciplined diversification. Learn how to position your portfolio for long-term stability, better risk management, and smarter expected returns.

#vanguardforecast #lostdecade #investing2025 #doctorfinance #moneymattersmd #valueinvesting #internationalstocks #assetallocation #portfoliostrategy #financialeducation #longterminvesting